XML 54 R35.htm IDEA: XBRL DOCUMENT v3.25.0.1
Vibativ®, Sancuso® and RediTrex® Products (Tables)
12 Months Ended
Dec. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
Schedule of Business Acquisitions by Acquisition, Contingent Consideration
The following table presents the changes in the fair value of the contingent consideration liability that is remeasured on a recurring basis. The contingent consideration earned and accrued in operating expenses is paid to Theravance annually.
Contingent Consideration Liability
Balance at December 31, 2022$4,154,823 
Cash payment of royalty during the period(1,018,451)
Change in fair value(270,485)
Contingent consideration earned and accrued1,167,486 
Balance at December 31, 2023$4,033,373 
Cash payment of royalty during the period(817,387)
Change in fair value(668,976)
Contingent consideration earned and accrued695,989 
Balance at December 31, 2024$3,242,999 
The following table presents the changes in the fair value of the contingent consideration liability that is remeasured on a recurring basis.
Contingent Consideration Liability
Balance at December 31, 2022
$3,000,000 
Cash payment of royalty during the period
(790,632)
Change in fair value
(685,355)
Contingent consideration earned and accrued
781,987 
Balance at December 31, 2023
$2,306,000 
Cash payment of royalty during the period
(898,686)
Change in fair value
(791,828)
Contingent consideration earned and accrued
900,514 
Balance at December 31, 2024
$1,516,000